# Phase I Clinical Trial to Assess Safety of UV Phototherapy for the Prevention of GVHD Post Allogeneic SCT

> **NCT00524953** · PHASE1 · WITHDRAWN · sponsor: **Hadassah Medical Organization**

## Conditions studied

- Allogeneic Transplantation (Non T-cell Depleted)

## Interventions

- **DEVICE:** EUMATRON - EN 600 NT

## Key facts

- **NCT ID:** NCT00524953
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-09
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00524953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00524953, "Phase I Clinical Trial to Assess Safety of UV Phototherapy for the Prevention of GVHD Post Allogeneic SCT". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00524953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*